The quest for safer and more effective therapies for pancreatic cancer has led researchers in Hiroshima to explore an unexpected avenue: a common natural sweetener, transformed through fermentation into a compound with selective cytotoxicity against cancer cells. They set out with a simple idea—enhance a stevia extract by fermentation to release a compound that targets malignant cells.
Using a strain of Lactobacillus plantarum derived from banana leaves, the team fermented stevia leaf extract and produced a molecule called chlorogenic acid methyl ester (CAME). In laboratory tests, CAME exhibited strong anticancer activity against pancreatic cancer cells, while sparing healthy kidney cells, suggesting a remarkable safety profile.
Moreover, the fermented extract demonstrated enhanced antioxidant properties. In assays, it neutralized free radicals and protected normal cells from hydrogen peroxide–induced oxidative damage more effectively than the non-fermented extract. This indicates that fermentation intensified the bioactive benefits of the stevia.
The fermented extract also suppressed cancer cell proliferation and migration, reduced colony formation, and inhibited wound closure in cancer cell cultures—evidence of a multi-pronged antitumor effect. Chromatography and spectroscopy confirmed CAME as the active molecule, present in significant concentration post-fermentation.
It’s important to maintain perspective: these findings are limited to in vitro cell models. There’s a long road ahead—animal studies, safety evaluations, dose optimization, and human clinical trials. Proof in a dish does not guarantee real-world impact.
What’s exciting is the proof of concept: that natural compounds, enhanced by fermentation, could emerge as therapeutic agents or adjuncts. A sugar substitute, common in low-calorie diets, transformed into a therapeutic molecule underscores the intersection of everyday life and applied science.
Given the lethality and resistance of pancreatic cancer, CAME represents a potential starting point for less toxic, more selective therapies. If future studies confirm its effectiveness, we may be looking at a paradigm shift: using modified natural compounds to target one of the deadliest cancers with precision.
Add comment
Comments